Skip to main navigation Skip to search Skip to main content

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial

  • STOP-COVID19 Investigators
  • , Holly R Keir
  • , Merete B Long
  • , Hani Abo-Leyah
  • , Yan Hui Giam
  • , Thenmalar Vadiveloo
  • , Thomas Pembridge
  • , Rebecca C Hull
  • , Lilia Delgado
  • , Margaret Band
  • , Fiona McLaren-Neil
  • , Simon Adamson
  • , Eva Lahnsteiner
  • , Amy Gilmour
  • , Chloe Hughes
  • , Benjamin JM New
  • , David Connell
  • , Rebecca Dowey
  • , Helena Turton
  • , Hollian Richardson
    • Diane Cassidy, Jamie Cooper, Jay Suntharalingam, Lavanya Diwakar, Peter Russell, Jonathan Underwood, Alexander Hicks, Davinder PS Dosanjh, Beth Sage, Devesh Dhasmana, Mark Spears, AA Roger Thompson, Christopher Brightling, Andrew Smith, Manish Patel, Jacob George, Alison M Condliffe, Amelia Shoemark, Graeme MacLennan, James D Chalmers*, James Chalmers, Christine Almaden-Boyle, Jennifer Taylor, Jodie Strachan, Heather Loftus, Lesley Young, Angela Strachan, Kristina Pilvinyte, David Miller, Gemma Cook, Jayne Wilson
*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

20   Link opens in a new tab Citations (Scopus)
12 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science